Squid Game is back—and this time, the knives are out. In the thrilling Season 3 premiere, Player 456 is spiraling and a brutal round of hide-and-seek forces players to kill or be killed. Hosts Phil Yu and Kiera Please break down Gi-hun’s descent into vengeance, Guard 011’s daring betrayal of the Game, and the shocking moment players are forced to choose between murdering their friends… or dying. Then, Carlos Juico and Gavin Ruta from the Jumpers Jump podcast join us to unpack their wild theories for the season. Plus, Phil and Kiera face off in a high-stakes round of “Hot Sweet Potato.” SPOILER ALERT! Make sure you watch Squid Game Season 3 Episode 1 before listening on. Play one last time. IG - @SquidGameNetflix X (f.k.a. Twitter) - @SquidGame Check out more from Phil Yu @angryasianman , Kiera Please @kieraplease and the Jumpers Jump podcast Listen to more from Netflix Podcasts . Squid Game: The Official Podcast is produced by Netflix and The Mash-Up Americans.…
Over 60 years ago, engineer Miles Lowell Edwards and surgeon Dr. Albert Starr launched a company and an industry by developing the first commercially available artificial heart valve. Today, Edwards Lifesciences is focusing its attention on developing life-saving and groundbreaking devices that can help patients with heart valve disease. In this podcast series, we'll talk with the Edwards Lifesciences leaders who are adding to this great MedTech story. This podcast is powered by DeviceTalks ...
…
continue reading

1
Edwards’ Joe Nuzzolese on planning for disruption, prioritizing patients & automating supply chains
35:14
35:14
Später Spielen
Später Spielen
Listen
Gefällt mir
Geliked
35:14In this episode of Structural Heart Talks, Joe Nuzzolese, corporate VP of global supply chain and quality at Edwards Lifesciences, shares how the company has built a resilient and responsive supply chain capable of withstanding significant disruptions—pandemic included—without missing a single patient case. Nuzzolese explains how Edwards takes a "p…
…
continue reading

1
Todd Brinton shares lessons on mentorship, Edwards’ culture and advancing heart failure innovation
40:46
40:46
Später Spielen
Später Spielen
Listen
Gefällt mir
Geliked
40:46In this episode of Structural Heart Talks, Todd Brinton, MD, Chief Scientific Officer & CVP, Advanced Technology at Edwards Lifesciences, discusses Edwards’ vision of future innovative technologies that elevate patient care and expand the possibilities of structural heart therapies. Brinton reflects on his journey from biomedical engineering to pio…
…
continue reading

1
Edwards’ Larry Wood discusses TAVR evolution, new clinical paradigms, and addressing treatment gaps
37:15
37:15
Später Spielen
Später Spielen
Listen
Gefällt mir
Geliked
37:15In this episode of Structural Heart Talks, Larry Wood, Corporate VP and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart at Edwards Lifesciences, discusses the transformative journey of transcatheter aortic valve replacement (TAVR) and the SAPIEN valve. Wood reflects on the innovation that enables minimally inva…
…
continue reading

1
Edwards surgical structural heart SVP Markowitz highlights culture, innovation, and making an impact
22:23
22:23
Später Spielen
Später Spielen
Listen
Gefällt mir
Geliked
22:23In this episode of Structural Heart Talks, Wayne Markowitz, General Manager and SVP, Surgical Structural Heart at Edwards Lifesciences, discussed the evolving landscape of the structural heart space, emphasizing the sharpened focus at Edwards under new leadership. Markowitz highlights the importance of the surgical structural heart business, with a…
…
continue reading

1
Daveen Chopra discusses Edwards’ mitral and tricuspid focus, PASCAL and EVOQUE, and patient impacts
37:21
37:21
Später Spielen
Später Spielen
Listen
Gefällt mir
Geliked
37:21In the inaugural episode of our newest podcast, Structural Heart Talks, we sit down with Daveen Chopra, Corporate VP and GM of Transcatheter Mitral and Tricuspid Therapies (TMTT) at Edwards Lifesciences. In the episode, Chopra discusses the unique challenges of advancing therapies for the mitral and tricuspid valves, which have historically been mo…
…
continue reading
Nearly 70 years ago, engineer Miles Lowell Edwards and surgeon Dr. Albert Starr launched a company and an industry by developing the first commercially available artificial heart valve. Today, Edwards Lifesciences is focusing its attention on developing life-saving and groundbreaking devices that can help patients with heart disease. Hosted by Tom …
…
continue reading